1. General Overview

  • Drug Class: Leukotriene receptor antagonist (LTRA).
  • Purpose: It works by blocking leukotrienes, substances in the body that cause inflammation, airway narrowing, and increased mucus production.

2. Indications

Montelukast is primarily prescribed for:

  • Asthma:
    • Used as a preventive medication for chronic asthma.
    • Helps reduce the frequency of asthma attacks, especially those triggered by exercise or allergens.
  • Allergic Rhinitis:
    • Treats seasonal and perennial allergic rhinitis symptoms, such as sneezing, runny nose, and nasal congestion.
  • Exercise-Induced Bronchoconstriction:
    • Prevents breathing problems during or after exercise.

3. Mechanism of Action

Montelukast blocks the cysteinyl leukotriene (CysLT1) receptor in the lungs and airways. Leukotrienes are chemical mediators released during allergic and inflammatory reactions that cause:

  • Bronchoconstriction (narrowing of airways),
  • Increased mucus production, and
  • Swelling (edema) in the respiratory passages.
    By inhibiting these effects, Montelukast improves airflow and reduces inflammation.

4. Dosage Forms

  • Tablets:
    • 10 mg (for adults and adolescents aged 15 and above).
  • Chewable Tablets:
    • 4 mg or 5 mg (for children aged 2–14 years).
  • Granules:
    • 4 mg (for infants aged 6 months to 5 years, mixed with food or liquids).

5. How to Take Montelukast

  • Usually taken once daily, in the evening, regardless of meals.
  • For asthma, it is not intended as a rescue medication (e.g., during an acute attack).
  • For exercise-induced symptoms, take 2 hours before physical activity (if prescribed for this purpose).

6. Side Effects

While Montelukast is generally well-tolerated, some people may experience:

  • Common Side Effects:
    • Headache
    • Abdominal pain
    • Fatigue
    • Nausea or diarrhea
  • Serious Side Effects (Rare):
    • Mood or behavioral changes (e.g., agitation, depression, anxiety, suicidal thoughts)
    • Allergic reactions (e.g., rash, swelling)
    • Churg-Strauss syndrome (rare vasculitis condition).

7. Warnings and Precautions

  • Behavioral Changes: Montelukast has been linked to neuropsychiatric side effects (e.g., mood swings, aggression). Patients should be monitored for such changes.
  • Not for Acute Asthma Attacks: Montelukast cannot replace fast-acting bronchodilators (e.g., albuterol).
  • Allergy Warning: Discontinue use if allergic reactions occur (e.g., swelling, rash).

8. Drug Interactions

Montelukast typically has minimal interactions, but caution is advised when combined with:

  • Phenobarbital and Rifampin: May reduce the effectiveness of Montelukast by increasing its metabolism.
  • Other medications affecting the liver enzymes (CYP3A4, CYP2C8, CYP2C9).

9. Use in Special Populations

  • Pregnancy: Classified as Category B (no evidence of risk in humans, but consult a doctor).
  • Breastfeeding: Data on excretion into breast milk is limited; consult a physician.
  • Children: Approved for use in children as young as 6 months (dose depends on age).

10. Monitoring and Effectiveness

  • For Asthma Control: Improvement can take several days to weeks of consistent use.
  • For Allergic Rhinitis: Symptom relief can begin within 1–2 days.
  • Regular check-ups with a healthcare provider are essential to evaluate efficacy and watch for side effects.
Scroll to Top